# Chebulagic Acid **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chebulagic-acid **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-29 **Evidence Score:** 4 / 10 **Category:** Compound **Also Known As:** Terminalia chebula tannin, Myrobalan ellagitannin, Chebulic acid derivative, Haritaki tannin, Black myrobalan tannin, Ellagitannin from T. chebula, Hydrolyzable tannin CA ## Overview Chebulagic acid is a hydrolyzable tannin extracted from Terminalia chebula that demonstrates potent anti-cancer and [anti-inflammatory](/ingredients/condition/inflammation) properties. This bioactive compound works by inducing apoptosis in cancer cells and inhibiting cyclooxygenase and lipoxygenase enzymes. ## Health Benefits • Anti-cancer properties: Preclinical studies show anti-proliferative effects against cancer cell lines (HCT-15, COLO-205, MDA-MB-231, DU-145, K562) via apoptosis induction (evidence: in vitro only) • Anti-inflammatory activity: Acts as a COX-LOX dual inhibitor (COX-1, COX-2, 5-LOX) reducing [inflammatory pathway](/ingredients/condition/inflammation)s (evidence: preclinical) • Antioxidant effects: Multiple hydroxyl groups enable strong free radical-scavenging properties (evidence: in vitro studies) • [Antimicrobial](/ingredients/condition/immune-support) action: Demonstrates antibacterial and antiviral properties in laboratory studies (evidence: preclinical) • [Lipid peroxidation](/ingredients/condition/antioxidant) protection: Shows anti-lipid peroxidation effects that may protect cellular membranes (evidence: preclinical) ## Mechanism of Action Chebulagic acid functions as a dual COX-LOX inhibitor, specifically targeting COX-1, COX-2, and 5-lipoxygenase enzymes to reduce inflammatory mediator production. The compound induces apoptosis in cancer cells through [mitochondrial](/ingredients/condition/energy) pathway activation and caspase cascade initiation. Its anti-inflammatory effects involve suppression of nuclear factor-kappa B (NF-κB) signaling and reduction of [pro-inflammatory cytokine](/ingredients/condition/inflammation) release. ## Clinical Summary Research on chebulagic acid is limited to preclinical in vitro studies demonstrating anti-proliferative effects against multiple cancer cell lines including HCT-15, COLO-205, MDA-MB-231, DU-145, and K562. Laboratory studies show significant apoptosis induction and [inflammatory](/ingredients/condition/inflammation) enzyme inhibition at micromolar concentrations. No human clinical trials have been conducted to establish safety, efficacy, or optimal dosing in humans. The evidence remains preliminary and requires extensive clinical validation before therapeutic applications can be recommended. ## Nutritional Profile Chebulagic acid is a pure bioactive compound (not a whole food), so classical macronutrient/micronutrient profiling does not apply. Molecular formula: C41H30O27; molecular weight: 954.65 g/mol. It is a hydrolyzable tannin (benzopyran-type) consisting of a glucose core esterified with gallic acid and ellagic acid moieties (specifically a DHHDP group and a chebuloyl group). As an isolated compound it contains no meaningful protein, fat, or dietary fiber content. Bioactive compound classification: polyphenol — hydrolyzable tannin subclass. Typical concentrations in source plants: found in Terminalia chebula fruits at approximately 0.5–3.2% dry weight depending on extraction method and fruit maturity; also present in smaller amounts in Terminalia bellerica and Phyllanthus emblica. Bioavailability is inherently limited due to high molecular weight (~955 Da) and poor passive intestinal absorption; gut microbiota hydrolyze it into smaller bioactive metabolites including ellagic acid, gallic acid, and urolithins (urolithin A, urolithin B), which are the primary systemically absorbed forms. Oral bioavailability of intact chebulagic acid is estimated to be low (<5% absorbed as parent compound). Stability is pH-dependent: relatively stable under acidic gastric conditions but susceptible to alkaline hydrolysis. No caloric value, vitamins, or minerals are contributed by this compound in isolation. LogP value approximately -1.2, indicating high hydrophilicity, which limits membrane permeability but supports aqueous solubility (~0.5 mg/mL in water). ## Dosage & Preparation No clinically studied dosage ranges for chebulagic acid in humans have been established. Commercial products offer ≥95-99% pure powder, but standardization details from human studies are unavailable. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for chebulagic acid supplementation in humans is currently unavailable due to lack of clinical trials. Potential interactions with anticoagulant medications may occur given its structural similarity to other tannins that affect platelet function. Gastrointestinal irritation could potentially occur at high doses, similar to other hydrolyzable tannins. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data and unknown effects on fetal development. ## Scientific Research No human clinical trials, RCTs, or meta-analyses specifically on chebulagic acid were identified in the available research. All evidence is limited to preclinical studies including in vitro anti-proliferative effects against various cancer cell lines and mechanistic studies on COX/LOX inhibition. ## Historical & Cultural Context Chebulagic acid derives from Terminalia chebula fruits, a key species in Ayurveda and traditional Chinese medicine used historically for [digestive health](/ingredients/condition/gut-health) and [antioxidant](/ingredients/condition/antioxidant) effects. The plant's tannins, including chebulagic acid, comprise approximately 32% of fruit content and have been used for centuries in traditional remedies. ## Synergistic Combinations Ellagic acid, gallic acid, vitamin C, quercetin, green tea extract ## Frequently Asked Questions ### What foods contain chebulagic acid naturally? Chebulagic acid is primarily found in Terminalia chebula (black myrobalan) fruits, with concentrations ranging from 2-4% by dry weight. Smaller amounts may be present in other Terminalia species and certain oak species, but T. chebula remains the primary commercial source. ### How much chebulagic acid should I take daily? No established dosage exists for chebulagic acid supplementation as human clinical trials have not been conducted. Laboratory studies used concentrations of 10-100 micromolar, but this cannot be directly translated to human dosing without safety studies. ### Can chebulagic acid help with arthritis inflammation? Laboratory studies show chebulagic acid inhibits COX-1, COX-2, and 5-LOX enzymes involved in inflammatory processes. However, no human studies have tested its effectiveness for arthritis or other inflammatory conditions, making clinical recommendations premature. ### Is chebulagic acid safe to take with blood thinners? Potential interactions with anticoagulant medications may exist due to chebulagic acid's tannin structure and possible effects on platelet function. Consult healthcare providers before combining with warfarin, aspirin, or other blood-thinning medications. ### What's the difference between chebulagic acid and other tannins? Chebulagic acid is a hydrolyzable tannin with unique dual COX-LOX inhibitory activity and specific anti-cancer properties against multiple cell lines. Unlike condensed tannins, it can be hydrolyzed into gallic acid and ellagic acid metabolites with distinct biological activities. ### What does clinical research show about chebulagic acid's anti-cancer potential? In vitro laboratory studies demonstrate that chebulagic acid induces apoptosis (programmed cell death) in several cancer cell lines including HCT-15 (colon), COLO-205 (colon), MDA-MB-231 (breast), DU-145 (prostate), and K562 (leukemia). However, these results are limited to test-tube and cell culture experiments; human clinical trials have not yet been conducted to establish safety or efficacy in cancer treatment. Current evidence is insufficient to recommend chebulagic acid as a cancer therapy, and it should not replace conventional medical treatment. ### How does chebulagic acid work as an anti-inflammatory compound? Chebulagic acid functions as a dual COX-LOX inhibitor, simultaneously blocking cyclooxygenase (COX-1 and COX-2) and 5-lipoxygenase (5-LOX) enzymes that drive inflammatory pathways in the body. This dual mechanism is similar to how some prescription anti-inflammatory medications work, but preclinical evidence shows this activity only in laboratory models. Human studies are needed to determine whether this mechanism translates to meaningful anti-inflammatory benefits in real-world supplementation. ### Who should avoid chebulagic acid supplementation? People taking anticoagulant or antiplatelet medications (such as warfarin or aspirin) should consult their healthcare provider before using chebulagic acid, as its tannin content may potentiate bleeding risk. Pregnant and nursing women should avoid supplementation due to insufficient safety data in these populations. Individuals with certain gastrointestinal conditions or those taking iron supplements may experience reduced mineral absorption due to chebulagic acid's tannin properties. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*